Upregulation of prostate-specific membrane antigen after androgen-deprivation therapy
- 31 August 1996
- journal article
- research article
- Published by Elsevier BV in Urology
- Vol. 48 (2), 326-334
- https://doi.org/10.1016/s0090-4295(96)00184-7
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Detection and characterization of the prostate‐specific membrane antigen (PSMA) in tissue extracts and body fluidsInternational Journal of Cancer, 1995
- Expression of prostate-specific membrane antigen in normal, benign, and malignant prostate tissuesUrologic Oncology: Seminars and Original Investigations, 1995
- Radioimmunoscintigraphy of Pelvic Lymph Nodes with111Indium-Labeled Monoclonal Antibody CYT-356Journal of Urology, 1994
- Radioimmunoscintigraphy with111Indium Labeled Cyt-356 for the Detection of Occult Prostate Cancer RecurrenceJournal of Urology, 1994
- Cytotoxic chemotherapy for advanced hormone-resistant prostate cancerCancer, 1993
- Pathologic changes associated with androgen deprivation therapy for prostate cancerCancer, 1991
- Immunoscintigraphy of prostatic cancer: Preliminary results with 111in‐labeled monoclonal antibody 7E11‐C5.3 (CYT‐356)The Prostate, 1991
- Prostate Specific Antigen in the Diagnosis and Treatment of Adenocarcinoma of the Prostate. IV. Anti-Androgen Treated PatientsJournal of Urology, 1989
- Changes in immunohistochemical staining in prostatic adenocarcinoma following diethylstilbestrol therapyThe Prostate, 1985
- Endocrine Therapy in Carcinoma of the Prostate Gland: 10-Year Survival StudiesJournal of Urology, 1960